Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Malats

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
Nature Communications|December 8, 2022
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin AS Mouron, M J Bueno, A Lluch, et al.
International Journal of Epidemiology|January 13, 2018
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relativesE Molina-Montes, P Gomez-Rubio, M Márquez, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European studyV Rosato, P Gómez-Rubio, E Molina-Montes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer riskP Gomez-Rubio, V Rosato, M Márquez, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
Nature Communications|December 8, 2022
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin AS Mouron, M J Bueno, A Lluch, et al.
International Journal of Epidemiology|January 13, 2018
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relativesE Molina-Montes, P Gomez-Rubio, M Márquez, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European studyV Rosato, P Gómez-Rubio, E Molina-Montes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer riskP Gomez-Rubio, V Rosato, M Márquez, et al.
Pageof 8